Free shipping on all orders over $ 500

Brequinar Sodium

Cat. No. M20779
Brequinar Sodium Structure
Synonym:

Bipenquinate, BRQ, DUP-785, NSC 368390

Size Price Availability Quantity
5mg USD 160  USD160 In stock
10mg USD 250  USD250 In stock
25mg USD 470  USD470 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Brequinar Sodium (Bipenquinate, BRQ, DUP-785, NSC 368390) is a potent and selective dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of ~20 nM and triggers differentiation in the ER-HoxA9, U937, and THP1 cells with ED50 of ~1 μM.

Chemical Information
Molecular Weight 397.35
Formula C23H14F2NNaO2
CAS Number 96201-88-6
Solubility (25°C) DMSO 79 mg/mL
Water 26 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Chao Mao, et al. Nature. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer

[2] Rui Su, et al. Cancer Cell. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion

[3] Godefridus J Peters. Nucleosides Nucleotides Nucleic Acids. Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor

[4] D V Cramer. Transplant Proc. Brequinar sodium

[5] D V Cramer. Pediatr Nephrol. Brequinar sodium

Related DHODH Products
DHODH-IN-13

DHODH-IN-13 is a hydroxyfurazan analog of A771726 and a dihydroorotic acid dehydrogenase (DHODH) inhibitor with an IC50 of 4.3 μM for hepatic DHODH in rats.DHODH-IN-13 can be used in rheumatoid arthritis-related studies.

DHODH-IN-12

DHODH-IN-12 is a Leflunomide derivative and a weak inhibitor of dihydroorotic acid dehydrogenase (DHODH), with a pKa of 5.07.

hDHODH-IN-5

hDHODH-IN-5 is a human dihydroorotic acid dehydrogenase (DHODH) inhibitor with an IC50 of 0.91 μM. hDHODH-IN-7 induces differentiation of acute myeloid leukemia cells.

DHODH-IN-8

DHODH-IN-8 is an inhibitor of human and Plasmodium falciparum dihydroorotic acid dehydrogenase (DHODH) with IC50s of 0.13 μM and 47.4 μM and Ki of 0.016 μM and 5.6 μM, respectively.DHODH-IN-8 exhibits antimalarial activity.

DHODH-IN-14

DHODH-IN-14 is a hydroxyfurazan analog of A771726 and a dihydroorotic acid dehydrogenase (DHODH) inhibitor with an IC50 of 0.49 μM for hepatic DHODH in rats.DHODH-IN-14 can be used in rheumatoid arthritis-related studies.

  Catalog
Abmole Inhibitor Catalog




Keywords: Brequinar Sodium, Bipenquinate, BRQ, DUP-785, NSC 368390 supplier, DHODH, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.